Hepatocellular carcinoma with gastric adenocarcinoma treated with
atezolizumab and bevacizumab
- Takayoshi Suga,
- Yuko Kimura,
- Kensuke Furuya,
- Hiroko Sato
Abstract
Hepatocellular carcinoma concurent with gastric adenocarcinoma is a rare
but possible case. In addition, selecting an effective treatment for two
primary cancers is often difficult. In this report, we present the first
case of hepatocellular carcinoma concurent with gastric adenocarcinoma
treated with atezolizumab and bevacizumab combination therapy.14 Jun 2023Submitted to Clinical Case Reports 20 Jun 2023Submission Checks Completed
20 Jun 2023Assigned to Editor
26 Jun 2023Reviewer(s) Assigned
21 Jul 2023Review(s) Completed, Editorial Evaluation Pending
19 Aug 2023Editorial Decision: Accept